Molina, E. J., Ahmed, M. M., Sheikh, F. H., Cleveland, J. C., Goldstein, D. J., Uriel, N. Y., Wang, A., Revis, J. J., & Mehra, M. R. (2024). Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.09.019

Shetty, N. S., Gaonkar, M., Pampana, A., Patel, N., Morrison, A. C., Reiner, A. P., Carson, A. P., Yu, B., Psaty, B. M., Kooperberg, C., Fatkin, D., Boerwinkle, E., Rotter, J. I., Taylor, K. D., Hou, L., Irvin, M. R., Hall, M. E., Maurer, M., Fornage, M., … Arora, P. (2024). Cardiovascular Risk Factors and Genetic Risk in Transthyretin V142I Carriers. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.08.019

Ilonze, O. J., Forman, D. E., LeMond, L., Myers, J., Hummel, S., Vest, A. R., DeFilippis, E. M., Habib, E., & Goodlin, S. J. (2024). Beyond Guideline-Directed Medical Therapy. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.08.018

Shah, P., Sayer, G., Sinha, S. S., Kanwar, M. K., Cowger, J. A., Pagani, F. D., Nayak, A., Mehra, M. R., Cleveland, J. C., Psotka, M. A., Singh, R., Desai, S. S., Lu, Q., Hu, Y., Connolly, A., Kormos, R. L., & Uriel, N. (2024). Dynamic Risk Estimation of Adverse Events in Ambulatory LVAD Patients. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.05.018

Taylor, C. N., Ibrahim, N. E., & Youmans, Q. R. (2024). The Quagmire of Prognostication in Heart Failure. JACC: Heart Failure, 12(5), 890–892. https://doi.org/10.1016/j.jchf.2024.02.026

Goyal, P., Maurer, M. S., & Roh, J. (2024). Aging in Heart Failure. JACC: Heart Failure, 12(5), 795–809. https://doi.org/10.1016/j.jchf.2024.02.021

Adamson, P. B., Echols, M., DeFilippis, E. M., Morris, A. A., Bennett, M., Abraham, W. T., Lindenfeld, J., Teerlink, J. R., O’Connor, C. M., Connolly, A. T., Li, H., Fiuzat, M., Vaduganathan, M., Vardeny, O., Batchelor, W., & McCants, K. C. (2024). Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations. JACC: Heart Failure, 12(7), 1212–1222. https://doi.org/10.1016/j.jchf.2024.02.015

Ostrominski, J. W., DeFilippis, E. M., Bansal, K., Riello, R. J., Bozkurt, B., Heidenreich, P. A., & Vaduganathan, M. (2024). Contemporary American and European Guidelines for Heart Failure Management. JACC: Heart Failure, 12(5), 810–825. https://doi.org/10.1016/j.jchf.2024.02.020

Brener, M. I., Kanwar, M. K., Lander, M. M., Hamid, N. B., Raina, A., Sethi, S. S., Finn, M. T., Fried, J. A., Raikhelkar, J., Masoumi, A., Rosenblum, H. R., Maurer, M. S., Sayer, G., Burkhoff, D., & Uriel, N. (2024). Impact of Interventricular Interaction on Ventricular Function. JACC: Heart Failure, 12(7), 1179–1192. https://doi.org/10.1016/j.jchf.2023.12.001

Liang, L. W., Lumish, H. S., Sewanan, L. R., Shimada, Y. J., Maurer, M. S., Weiner, S. D., Sayer, G., Uriel, N., & Clerkin, K. J. (2023). Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy. JACC: Heart Failure, 11(11), 1473–1480. https://doi.org/10.1016/j.jchf.2023.07.004

Ramu, B., Cogswell, R., Ravichandran, A. K., Cleveland, J., Mehra, M. R., Goldstein, D., Uriel, N., Dirckx, N., Ahmed, S., & Yuzefpolskaya, M. (2023). Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men. JACC: Heart Failure, 11(12), 1692–1704. https://doi.org/10.1016/j.jchf.2023.08.020

Patel, R. B., Reddy, V. Y., Komtebedde, J., Wegerich, S. W., Sekaric, J., Swarup, V., Walton, A., Laurent, G., Chetcuti, S., Rademann, M., Bergmann, M., McKenzie, S., Bugger, H., Bruno, R. R., Herrmann, H. C., Nair, A., Gupta, D. K., Lim, S., Kapadia, S., … Shah, S. J. (2023). Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure, 11(10), 1351–1362. https://doi.org/10.1016/j.jchf.2023.05.024

DeFilippis, E. M., Bhagra, C., Casale, J., Ging, P., Macera, F., Punnoose, L., Rasmusson, K., Sharma, G., Sliwa, K., Thorne, S., Walsh, M. N., & Kittleson, M. M. (2023). Cardio-Obstetrics and Heart Failure. JACC: Heart Failure, 11(9), 1165–1180. https://doi.org/10.1016/j.jchf.2023.07.009

DeFilippis, E. M., Nikolova, A., Holzhauser, L., & Khush, K. K. (2023). Understanding and Investigating Sex-Based Differences in Heart Transplantation. JACC: Heart Failure, 11(9), 1181–1188. https://doi.org/10.1016/j.jchf.2023.06.030

Lander, M. M., Brener, M. I., Goel, K., Tang, P. C., Verlinden, N. J., Zalawadiya, S., Lindenfeld, J., & Kanwar, M. K. (2023). Mitral Interventions in Heart Failure. JACC: Heart Failure, 11(8), 1055–1069. https://doi.org/10.1016/j.jchf.2023.07.016

Hahn, R. T., Brener, M. I., Cox, Z. L., Pinney, S., & Lindenfeld, J. (2023). Tricuspid Regurgitation Management for Heart Failure. JACC: Heart Failure, 11(8), 1084–1102. https://doi.org/10.1016/j.jchf.2023.07.020

Cox, Z. L., Zalawadiya, S. K., Simonato, M., Redfors, B., Zhou, Z., Kotinkaduwa, L., Zile, M. R., Udelson, J. E., Lim, D. S., Grayburn, P. A., Mack, M. J., Abraham, W. T., Stone, G. W., & Lindenfeld, J. (2023). Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation. JACC: Heart Failure, 11(7), 791–805. https://doi.org/10.1016/j.jchf.2023.03.009

Abadie, B. Q., Chan, N., Sharalaya, Z., Bhat, P., Harb, S., Jacob, M., Starling, R. C., Tang, W. H. W., Cremer, P. C., & Jaber, W. A. (2023). Negative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV. JACC: Heart Failure, 11(5), 555–565. https://doi.org/10.1016/j.jchf.2022.11.012

Holzhauser, L., DeFilippis, E. M., Nikolova, A., Byku, M., Contreras, J. P., De Marco, T., Hall, S., Khush, K. K., & Vest, A. R. (2023). The End of Endomyocardial Biopsy? JACC: Heart Failure, 11(3), 263–276. https://doi.org/10.1016/j.jchf.2022.11.002

Amdani, S., Conway, J., Kleinmahon, J., Auerbach, S., Hsu, D., Cousino, M. K., Kaufman, B., Alejos, J., Cruz, J. H., Lee, H. Y., Rudraraju, R., Kirklin, J. K., & Asante-Korang, A. (2023). Race and Socioeconomic Bias in Pediatric Cardiac Transplantation. JACC: Heart Failure, 11(1), 19–26. https://doi.org/10.1016/j.jchf.2022.08.021

Mehra, M. R., Nayak, A., Morris, A. A., Lanfear, D. E., Nemeh, H., Desai, S., Bansal, A., Guerrero-Miranda, C., Hall, S., Cleveland, J. C., Goldstein, D. J., Uriel, N., Chen, L., Bailey, S., Anyanwu, A., Heatley, G., Chuang, J., & Estep, J. D. (2022). Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. JACC: Heart Failure, 10(12), 948–959. https://doi.org/10.1016/j.jchf.2022.08.002

Molinsky, R. L., Yuzefpolskaya, M., Norby, F. L., Yu, B., Shah, A. M., Pankow, J. S., Ndumele, C. E., Lutsey, P. L., Papapanou, P. N., Beck, J. D., Colombo, P. C., & Demmer, R. T. (2022). Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure. JACC: Heart Failure, 10(10), 731–741. https://doi.org/10.1016/j.jchf.2022.05.008

Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, T., Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, L., Fiuzat, M., & McMurray, J. J. V. (2022). Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score. JACC: Heart Failure, 10(8), 543–555. https://doi.org/10.1016/j.jchf.2022.03.009

Vidula, H., Takeda, K., Estep, J. D., Silvestry, S. C., Milano, C., Cleveland, J. C., Goldstein, D. J., Uriel, N., Kormos, R. L., Dirckx, N., & Mehra, M. R. (2022). Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. JACC: Heart Failure, 10(7), 470–481. https://doi.org/10.1016/j.jchf.2022.03.007

Clerkin, K. J., Salako, O., Fried, J. A., Griffin, J. M., Raikhelkar, J., Jain, R., Restaino, S., Colombo, P. C., Takeda, K., Farr, M. A., Sayer, G., Uriel, N., & Topkara, V. K. (2022). Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System. JACC: Heart Failure, 10(1), 12–23. https://doi.org/10.1016/j.jchf.2021.08.003